Corporate News

AlzChem Group AG: Placement of shares of majority shareholders successfully completed

Trostberg, October 17, 2018 - AlzChem Group AG's (ISIN: DE000A0AHT46, ticker: SFP1) three majority shareholders, namely LIVIA Corporate Development SE, HDI Vier CE GmbH, and four two na GmbH, successfully sold in total 20,454,546 existing bearer shares with no par value in AlzChem Group AG, corresponding to approximately 20.1% of all outstan

Andreas Niedermaier becomes new CEO – Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019

Trostberg, June 3, 2019 – The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view of the resignation of the current CEO Mr. Ulli Seibel as of December 31, 2019. In this function, Mr. Niedermaier will also be responsible for Investor Relations and Communications. Dr. Georg Weichselbaumer was newly appointed to the Management Board effective July 1, 2019. Dr.

AlzChem Group AG: Annual General Meeting approves dividend of EUR 0.09 per share

Trostberg, May 14, 2019 – At today's Annual General Meeting of AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, the shareholders present honored the successful business development and corporate strategy and expressed their confidence in the Management Board and Supervisory Board. All items on the agenda were resolved by a large majority in the interests of management, which included a dividend payment of EUR 0.09 per share and, among other things, a reverse stock split of 10 to 1.

AlzChem Group launches LIVADUR®, its first product for end customers

Trostberg, March 15, 2019 – With its creatine product LIVADUR®, AlzChem Group AG will be addressing end consumers directly for the first time as of March 2019. The target audience consists of active people aged 55 and over who want to prevent the age-related decline in muscle strength and thus maintain their high quality of life and fitness. The dietary supplement is based on the already very successful product Creapure®, the only creatine product manufactured in Germany that is supplied to the dietary supplement industry specifically for sports nutrition.

Annual General Meeting approves dividend payment of EUR 0.11 per share

Trostberg, November 22, 2018 – The shareholders of AlzChem Group AG, a vertically integrated specialty chemicals supplier with leading market positions in selected niche markets, approved all agenda items with a large majority at today's Annual General Meeting. In addition to the discharge of the Management Board and Supervisory Board, it was also decided to pay a dividend of EUR 0.11 per share to the shareholders. Furthermore, the Annual General Meeting agreed to change the fiscal year and to have it begin on January 1 of each year and end on December 31 of each year.